Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model.

Rabaça AN, Arruda DC, Figueiredo CR, Massaoka MH, Farias CF, Tada DB, Maia VC, Silva Junior PI, Girola N, Real F, Mortara RA, Polonelli L, Travassos LR.

FEBS Open Bio. 2016 Jul 15;6(9):885-901. doi: 10.1002/2211-5463.12080. eCollection 2016 Sep.

2.

Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth.

Gupta R, Forloni M, Bisserier M, Dogra SK, Yang Q, Wajapeyee N.

Elife. 2016 Sep 8;5. pii: e16432. doi: 10.7554/eLife.16432.

3.

Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.

Patel PL, Suram A, Mirani N, Bischof O, Herbig U.

Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E5024-33. doi: 10.1073/pnas.1602379113. Epub 2016 Aug 8.

4.

Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.

Sinnberg T, Wang J, Sauer B, Schittek B.

BMC Cancer. 2016 Aug 3;16:594. doi: 10.1186/s12885-016-2643-0.

5.

Emerging options for the treatment of melanoma - focus on ipilimumab.

Roddie C, Peggs KS.

Immunotargets Ther. 2014 Mar 17;3:67-78. doi: 10.2147/ITT.S43522. eCollection 2014. Review.

6.

BRAF Mutation (V600E) Prevalence in Mexican Patients Diagnosed with Melanoma.

Zepeda-Lopez PD, Salas-Alanis JC, Toussaint-Caire S, Gutierrez-Mendoza D, Vega-Memije E, Silva SL, Fajardo-Ramírez OR, Alcazar G, Moreno-Treviño MG, Saldaña HA.

Case Rep Oncol. 2016 Apr 21;9(1):241-5. doi: 10.1159/000445939. eCollection 2016 Jan-Apr.

7.

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.

Tel J, Koornstra R, de Haas N, van Deutekom V, Westdorp H, Boudewijns S, van Erp N, Di Blasio S, Gerritsen W, Figdor CG, de Vries IJ, Hato SV.

J Transl Med. 2016 Apr 14;14:88. doi: 10.1186/s12967-016-0844-6.

8.

miR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1.

Tian F, Wei H, Tian H, Qiu Y, Xu J.

Oncol Lett. 2016 Apr;11(4):2741-2746. Epub 2016 Mar 9.

9.

Eleven Primary Melanomas, Colon Cancer, and Atypical Nevi in the Same Patient: A Case Report and Literature Review.

Juul Nielsen L, Rosenkrantz Hölmich L.

Case Rep Dermatol Med. 2016;2016:3145986. doi: 10.1155/2016/3145986. Epub 2016 Feb 28.

10.

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer.

Pappalardo F, Russo G, Candido S, Pennisi M, Cavalieri S, Motta S, McCubrey JA, Nicoletti F, Libra M.

PLoS One. 2016 Mar 25;11(3):e0152104. doi: 10.1371/journal.pone.0152104. eCollection 2016.

11.

Toward in vivo biopsy of melanoma based on photoacoustic and ultrasound dual imaging with an integrated detector.

Wang Y, Xu D, Yang S, Xing D.

Biomed Opt Express. 2016 Jan 5;7(2):279-86. doi: 10.1364/BOE.7.000279. eCollection 2016 Feb 1.

12.

Amelanotic Melanoma in the Vicinity of Acquired Melanocytic Nevi and not Arising from Agminated Melanocytic Nevi: Masquerading as Pyogenic Granuloma.

Rao AG, Babu VA, Koppada D, Haritha M, Chandana P, Swapna, Anoosha.

Indian J Dermatol. 2016 Jan-Feb;61(1):122. doi: 10.4103/0019-5154.174135.

13.

Salmonella VNP20009-mediated RNA interference of ABCB5 moderated chemoresistance of melanoma stem cell and suppressed tumor growth more potently.

Zhang X, Cheng X, Lai Y, Zhou Y, Cao W, Hua ZC.

Oncotarget. 2016 Mar 22;7(12):14940-50. doi: 10.18632/oncotarget.7496.

14.

Melanin content in melanoma metastases affects the outcome of radiotherapy.

Brożyna AA, Jóźwicki W, Roszkowski K, Filipiak J, Slominski AT.

Oncotarget. 2016 Apr 5;7(14):17844-53. doi: 10.18632/oncotarget.7528.

15.

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.

Jayachandran A, Lo PH, Chueh AC, Prithviraj P, Molania R, Davalos-Salas M, Anaka M, Walkiewicz M, Cebon J, Behren A.

BMC Cancer. 2016 Feb 22;16:134. doi: 10.1186/s12885-016-2185-5.

16.

Characteristics and Treatment of Cutaneous Melanoma of the Foot.

Nam KW, Bae YC, Nam SB, Kim JH, Kim HS, Choi YJ.

Arch Plast Surg. 2016 Jan;43(1):59-65. doi: 10.5999/aps.2016.43.1.59. Epub 2016 Jan 15.

17.

Inhibition of the RhoA GTPase Activity Increases Sensitivity of Melanoma Cells to UV Radiation Effects.

Espinha G, Osaki JH, Costa ET, Forti FL.

Oxid Med Cell Longev. 2016;2016:2696952. doi: 10.1155/2016/2696952. Epub 2015 Dec 28.

18.

Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma.

Vennepureddy A, Thumallapally N, Motilal Nehru V, Atallah JP, Terjanian T.

J Clin Med Res. 2016 Feb;8(2):63-75. doi: 10.14740/jocmr2424w. Epub 2015 Dec 28. Review.

19.

Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.

Heise R, Amann PM, Ensslen S, Marquardt Y, Czaja K, Joussen S, Beer D, Abele R, Plewnia G, Tampé R, Merk HF, Hermanns HM, Baron JM.

PLoS One. 2016 Jan 6;11(1):e0146325. doi: 10.1371/journal.pone.0146325. eCollection 2016.

20.

Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.

Wang K, Zhang ZW.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13249-54. eCollection 2015.

Items per page

Supplemental Content

Write to the Help Desk